Emphasize Merger’s Anticompetitive Consequences & Potential Harm to Consumers
The National Association of Chain Drug Stores (NACDS) and National Community Pharmacists Association (NCPA) – who represent a near totality of the nation’s pharmacy community – today commended the U.S. Federal Trade Commission (FTC) for issuing a "second request" - further investigation of the proposed merger of Express Scripts, Inc. and Medco Health Solutions, Inc.
NCPA Executive Vice President and CEO B. Douglas Hoey, RPh, MBA, and NACDS President and CEO Steven C. Anderson, IOM, CAE, issued the following joint statement:
"This is an important step in the careful consideration of a proposed merger that would have anticompetitive effects on patients, consumers, the market and the entire healthcare delivery system. As we indicated to the FTC in our formal letter, NACDS and NCPA are concerned that the merger would result in a consolidated pharmacy benefit manager (PBM) with excessive market power, ultimately to the detriment of consumers. As community pharmacies whose primary concern is patient well-being, we are concerned about the threat posed by the planned merger to patient care and pharmacy access. We will support the continued and comprehensive investigation of this issue."